NCT00470886View on ClinicalTrials.gov

Assessment of Compliance With Antihypertensive Telmisartan Therapy

CompletedOBSERVATIONAL
Enrollment

3,400

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Hypertension
Interventions
DRUG

Telmisartan (Kinzal/Pritor, BAY68-9291)

Primary care clinic hypertensive patients for whom physician decided to start the treatment with telmisartan

Trial Locations (2)

Unknown

Many Locations

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
collaborator

Bang & Olufsen Medicom

INDUSTRY

lead

Bayer

INDUSTRY